Fluoride
Sodium (Luride, Pediaflor, Pharmaflur, Gel-Kam, various) |
Category:
Description:
Indications:
Contraindications:
Precautions:
-
Pregnancy
and lactation: Administration from 3rd-9th month
of gestation safe (no information on teratogenicity); small amounts
excreted into breast milk, inadequate therapeutically due to small
amount of excretion and complexation with calcium
-
Drinking
water >0.7 ppm fluoride
Adverse
Reactions (Side Effects):
-
EENT:
watery eyes
-
GI:
black tarry stools, constipation, diarrhea, discoloration of teeth,
hematemesis, increased salivation, loss of appetite, nausea,
stomatitis, weight loss
-
METAB:
hypocalcemia
-
MS:
articular and juxta-articular pain, osteomalacia, stress fractures,
tetany
-
RESP:
decreased respiration, respiratory arrest
|
Dosage:
Administered
orally (drops, lozenges, tablets, rinse, gel)
NOTE:
2.2mg sodium fluoride equivalent to 1mg fluoride ion
-
Adult
and child >12 years:
-
Child:
-
Brush-on-gel: After brushing with toothpaste, >6 years apply thin ribbon of
gel to teeth with toothbrush for at least 1 minute at bedtime,
expectorate gel and rinse mouth thoroughly
-
Dental
rinse: TOP 5ml 0.2% solution daily after brushing teeth, rinse
mouth for >1 minute with solution then expectorate
-
Gel
drops: >6 years: use applicators supplied by dentist; apply
4-8 drops to inner surface of applicator, spread evenly with tip
of bottle; place applicator over upper and lower teeth and bite
down gently for 6 minutes; remove and rinse mouth
-
Systemic
protection from periodontal disease: PO in areas where fluoride
content of drinking water < 0.3 ppm, <2years 0.25mg fluoride
daily, 2-3 years 0.5mg daily, 3-12 years 1mg daily; in areas where
fluoride content of drinking water is 0.3-0.7 ppm, <2 years 0.125mg
fluoride daily, 2-3 years 0.25mg daily, 3-14 years 0.25-0.75mg daily
|
|
|
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
This information is provided by The Brookside Associates. The Brookside
Associates, LLC. is a private organization, not affiliated with any governmental
agency. The opinions presented here are those of the author and do not
necessarily represent the opinions of the Brookside Associates or the Department
of Defense. The presence of any advertising on these pages does not constitute
an endorsement of that product or service by either the US Department of Defense
or the Brookside Associates. All material presented here is unclassified.
C. 2009, 2014, All Rights Reserved
|
|